| ROR1 expression in mature B lymphoid neoplasms by flow cytometry. | ROR1 expression in mature B lymphoid neoplasms by flow cytometry.
de Sousa FA, Millan NM, Correia RP, da Costa Vaz A, Schimidell D, Miyamoto PC, Passaro MS, Nogueira BG, Souto EX, Bacal NS, Bento LC. | 02/27/2024 |
| The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer. | The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.
Meng S, Li M, Qin L, Lv J, Wu D, Zheng D, Jia H, Chen D, Wu Q, Long Y, Tang Z, Tang Y, Yang L, Yao Y, Luo X, Li P. | 11/8/2023 |
| Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition. | Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
Heabah NAE, Darwish SA, Eid AM. | 08/17/2023 |
| ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-kappaB signaling pathway. | ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway.
Huang W, Tang H, Liu Y, Li W, Shimu AS, Li B, Zhu C. | 07/27/2023 |
| IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. | IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
Lin W, Niu R, Park SM, Zou Y, Kim SS, Xia X, Xing S, Yang Q, Sun X, Yuan Z, Zhou S, Zhang D, Kwon HJ, Park S, Il Kim C, Koo H, Liu Y, Wu H, Zheng M, Yoo H, Shi B, Park JB, Yin J., Free PMC Article | 03/24/2023 |
| Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells. | Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells.
Ishikawa T, Ogura Y, Tanaka K, Nagashima H, Sasayama T, Endo M, Minami Y., Free PMC Article | 02/11/2023 |
| MIR-379-5p Expression in Endometrial Cancer and Its Correlation with ROR1 Expression. | MIR-379-5p Expression in Endometrial Cancer and Its Correlation with ROR1 Expression.
Mosaad H, Abdelrahman AE, Abdullatif A, Lashin ME, Ramadan MSH, El-Azony A, Hussien MHS., Free PMC Article | 02/4/2023 |
| ROR1: an orphan becomes apparent. | ROR1: an orphan becomes apparent.
Kipps TJ., Free PMC Article | 10/15/2022 |
| High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia. | High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia.
Ghia EM, Rassenti LZ, Choi MY, Quijada-Álamo M, Chu E, Widhopf GF 2nd, Kipps TJ., Free PMC Article | 06/11/2022 |
| Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1). | Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1).
Guarino SR, Di Bello A, Palamini M, Capillo MC, Forneris F., Free PMC Article | 05/14/2022 |
| Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer. | Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer.
Ma F, Arai S, Wang K, Calagua C, Yuan AR, Poluben L, Gu Z, Russo JW, Einstein DJ, Ye H, He MX, Liu Y, Van Allen E, Sowalsky AG, Bhasin MK, Yuan X, Balk SP., Free PMC Article | 04/30/2022 |
| miR-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1. | miR-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1.
Liang M, Chen H, Min J. | 03/19/2022 |
| SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression. | SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
Liu M, Shi Y, Hu Q, Qin Y, Ji S, Liu W, Zhuo Q, Fan G, Ye Z, Song C, Yu X, Xu X, Xu W. | 03/19/2022 |
| ROR1 and ROR2 expression in pancreatic cancer. | ROR1 and ROR2 expression in pancreatic cancer.
Liu D, Sharbeen G, Phillips P, Australian Pancreatic Cancer Genome Initiative, Ford CE., Free PMC Article | 02/26/2022 |
| Development of a DELFIA method to detect oncofetal antigen ROR1-positive exosomes. | Development of a DELFIA method to detect oncofetal antigen ROR1-positive exosomes.
Daikuzono H, Yamazaki M, Sato Y, Takahashi T, Yamagata K. | 01/29/2022 |
| Receptor tyrosine kinase ROR1 ameliorates Abeta1-42 induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer's disease. | Receptor tyrosine kinase ROR1 ameliorates Aβ(1-42) induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer's disease.
Chanda K, Jana NR, Mukhopadhyay D., Free PMC Article | 01/1/2022 |
| NF-kappaB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia. | NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia.
Sanchez-Lopez E, Ghia EM, Antonucci L, Sharma N, Rassenti LZ, Xu J, Sun B, Kipps TJ, Karin M., Free PMC Article | 09/25/2021 |
| Solution structure, dynamics and function investigation of Kringle domain of human receptor tyrosine kinase-like orphan receptor 1. | Solution structure, dynamics and function investigation of Kringle domain of human receptor tyrosine kinase-like orphan receptor 1.
Ma X, Liu B, Yang J, Hu K. | 08/28/2021 |
| Tumor microenvironment acidity modulates ROR1 to promote epithelial-mesenchymal transition and hepatocarcinoma metastasis. | Tumor microenvironment acidity modulates ROR1 to promote epithelial-mesenchymal transition and hepatocarcinoma metastasis.
Meng X, Xu Y, Ning X. | 07/24/2021 |
| Functional and clinical significance of ROR1 in lung adenocarcinoma. | Functional and clinical significance of ROR1 in lung adenocarcinoma.
Schiavone G, Epistolio S, Martin V, Molinari F, Barizzi J, Mazzucchelli L, Frattini M, Wannesson L., Free PMC Article | 05/15/2021 |
| Long noncoding RNA ROR1AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/beta-catenin/EMT signaling cascade in cervical cancer. | Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
Zhang L, Yao HR, Liu SK, Song LL. | 03/20/2021 |
| ROR1 is an accurate and reliable marker of minimal residual disease in chronic lymphocytic leukaemia. | ROR1 is an accurate and reliable marker of minimal residual disease in chronic lymphocytic leukaemia.
De Propris MS, Intoppa S, Milani ML, Mariglia P, Nardacci MG, Peragine N, Foà R, Guarini A. | 03/13/2021 |
| LncRNA ROR1-AS1 promotes colon cancer cell proliferation by suppressing the expression of DUSP5/CDKN1A. | LncRNA ROR1-AS1 promotes colon cancer cell proliferation by suppressing the expression of DUSP5/CDKN1A.
Wang XY, Jian X, Sun BQ, Ge XS, Huang FJ, Chen YQ. | 02/13/2021 |
| ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target. | ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Liu D, Gunther K, Enriquez LA, Daniels B, O'Mara TA, Tang K, Spurdle AB, Ford CE., Free PMC Article | 12/12/2020 |
| ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1. | ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1.
Fultang N, Illendula A, Lin J, Pandey MK, Klase Z, Peethambaran B., Free PMC Article | 11/21/2020 |